Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PeptiFinder provides mRNA display-centered drug discovery services, enabling rapid identification of potent and selective linear or macrocyclic peptide candidates. The company’s technology supports the development of diverse therapeutic molecules—including peptides, macrocycles, antibodies, ADCs, CAR-T therapies—by generating ultra-high diversity libraries and facilitating efficient hit-to-lead processes. No proprietary clinical results are reported as the company operates as a CRO/platform provider.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PeptiFinder Biotech.